mdl 100240 has been researched along with angiotensin i in 2 studies
| Studies (mdl 100240) | Trials (mdl 100240) | Recent Studies (post-2010) (mdl 100240) | Studies (angiotensin i) | Trials (angiotensin i) | Recent Studies (post-2010) (angiotensin i) |
|---|---|---|---|---|---|
| 21 | 9 | 0 | 4,218 | 125 | 1,253 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, T; Brunner-Ferber, F; Gardiner, SM; Kemp, PA | 1 |
| Biollaz, J; Brunner, HR; Brunner-Ferber, F; Buclin, T; Nussberger, J; Rousso, P | 1 |
1 trial(s) available for mdl 100240 and angiotensin i
| Article | Year |
|---|---|
Effects of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase on the vasopressor response to exogenous angiotensin I and angiotensin II challenges in healthy volunteers.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Area Under Curve; Benzazepines; Blood Pressure; Double-Blind Method; Enzyme Inhibitors; Humans; Male; Neprilysin; Placebos; Pyridines; Reference Values | 1998 |
1 other study(ies) available for mdl 100240 and angiotensin i
| Article | Year |
|---|---|
Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Benzazepines; Bradykinin; Endothelin-1; Hemodynamics; Male; Neprilysin; Protease Inhibitors; Pyridines; Rats | 1997 |